← Leaderboards
Whitney Barham
Mayo Clinic Rochester
$140,706
Attributed
$140,706
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.8K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$140,706 · 1
By mechanism
F30$140,706 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Ningling Kang$5,654,068
- Cornelia M Weyand$30,789,284
- Evanthia Galanis$13,573,895
- Haidong Dong$5,086,281
- Zhenkun Lou$18,569,951
Others in their field
Other Emerging Leaders on “Alternative Splicing”
- Justin B. Kinney · Cold Spring Harbor Laboratory$5,625,506
- Gudrun Stengel · Alida Biosciences, Inc.$4,719,386
- Adam Norris · Southern Methodist University$4,243,750
- Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary$3,794,243
- Rendong Yang · University Of Minnesota$3,719,045
- Georg Seelig · University Of Washington$3,676,436
Research focus
Alternative SplicingAntibodiesAnti-Pd-1Anti-Pd1 TherapyBindingBiopsyBlocking AntibodiesCancer CellCancer PatientCancer TypeCd8-Positive T-LymphocytesCell KillingCell MembraneCellsCessation Of LifeCheckpoint TherapyClinically SignificantCombined Modality TherapyCurative TreatmentsCytoplasmic GranulesCytotoxicCytotoxicityCytotoxic T-LymphocytesAffect
Grant awards (3)
Increasing the cytotoxicity of T cells in response to PD-1 blockade$48,750
F30 · FY2022 · CA · contact PI
Increasing the cytotoxicity of T cells in response to PD-1 blockade$46,236
F30 · FY2021 · CA · contact PI
Increasing the cytotoxicity of T cells in response to PD-1 blockade$45,720
F30 · FY2020 · CA · contact PI